ClinicalTrials.govpublic full text
Local Consolidative Radiation Therapy Plus TKI Versus TKI Alone in Driver Mutated OM-NSCLC
oligometastatic disease, non-small cell lung cancer, driver mutation, oligometastatic nsclc, tki, local consolidative therapy, sabr, oligometastases, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 837579
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.